ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

ClinicalTrials.gov ID: NCT07214779

Public ClinicalTrials.gov record NCT07214779. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 9, 2026, 8:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Open-Label Study of INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Study identification

NCT ID
NCT07214779
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Incyte Corporation
Industry
Enrollment
466 participants

Conditions and interventions

Conditions

Interventions

  • INCB123667 Drug
  • Investigator's choice of chemotherapy Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 8, 2025
Primary completion
Nov 14, 2028
Completion
May 13, 2029
Last update posted
May 7, 2026

2025 – 2029

United States locations

U.S. sites
26
U.S. states
19
U.S. cities
24
Facility City State ZIP Site status
Alaska Womens Cancer Care Akwcc Anchorage Alaska 99508 Not yet recruiting
City of Hope Medical Center Duarte California 91010 Not yet recruiting
Valkyrie Clinical Trials Los Angeles California 90067 Recruiting
University of Colorado Cancer Center Aurora Colorado 80045 Not yet recruiting
Georgia Cancer Center Augusta Georgia 30912 Not yet recruiting
Carle Cancer Center Effingham Illinois 62401-2006 Not yet recruiting
Northshore University Health System-Evanston Hospital Evanston Illinois 60201 Not yet recruiting
Women'S Cancer Care Covington Louisiana 70433 Not yet recruiting
Maine Center For Cancer Medicine Scarborough Maine 04074 Not yet recruiting
Holy Cross Hospital Silver Spring Maryland 20910 Not yet recruiting
Mercy Hospital St. Louis - David C. Pratt Cancer Center St Louis Missouri 63141 Not yet recruiting
Billings Clinic Billings Montana 59101 Recruiting
Center of Hope Reno Nevada 89502 Not yet recruiting
Levine Cancer Center Charlotte North Carolina 28204 Not yet recruiting
Novant Presbyterian Hospital Charlotte North Carolina 28204 Not yet recruiting
Novant Health Oncology Specialists Winston-Salem North Carolina 27103 Not yet recruiting
Atrium Health Wake Forest Baptist Winston-Salem North Carolina 27157 Not yet recruiting
Oncology Associates of Oregon, P.C. Eugene Oregon 97401 Not yet recruiting
Providence Cancer Institute Franz Clinic Portland Oregon 97213 Not yet recruiting
University of Pittsburgh Cancer Institute Cancer Services Pittsburgh Pennsylvania 15213 Not yet recruiting
Wellspan Gynecologic Oncology York Pennsylvania 17403 Not yet recruiting
Sanford Cancer Center-Sioux Falls Sioux Falls South Dakota 57104-8805 Not yet recruiting
Erlanger Health, Inc. Chattanooga Tennessee 37403 Recruiting
Texas Oncology-Abilene Abilene Texas 79606 Not yet recruiting
Inova Schar Cancer Institute Fairfax Virginia 22031 Not yet recruiting
Fred Hutchinson Cancer Center Seattle Washington 98109 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 136 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07214779, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 7, 2026 · Synced May 9, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07214779 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →